Wolverine Trading
LJPC

Wolverine Trading’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Wolverine Trading’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,000
Closed -$80K – 7445
2021
Q2 		$80K Buy
+18,000
New +$77.1K ﹤0.01% 5499
2021
Q1 		– Sell
-21,800
Closed -$87K – 6686
2020
Q4 		$87K Buy
+21,800
New +$93.2K ﹤0.01% 4503
2020
Q2 		– Sell
-12,300
Closed -$51K – 5635
2020
Q1 		$51K Sell
12,300
-2,300
-16% -$14.5K ﹤0.01% 4261
2019
Q4 		$57K Buy
+14,600
New +$86.2K ﹤0.01% 4434
2019
Q3 		– Sell
-12,400
Closed -$115K – 5445
2019
Q2 		$115K Sell
12,400
-4,700
-27% -$35.4K ﹤0.01% 3970
2019
Q1 		$110K Buy
+17,100
New +$111K ﹤0.01% 4102
2018
Q3 		– Sell
-6,800
Closed -$203K – 6572
2018
Q2 		$203K Hold
6,800
– – ﹤0.01% 4365
2018
Q1 		$203K Buy
+6,800
New +$219K ﹤0.01% 4365
2017
Q4 		– Sell
-6,800
Closed -$237K – 6022
2017
Q3 		$237K Buy
+6,800
New +$219K ﹤0.01% 3602

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Wolverine Trading's LJPC Position: Q2 2020 in Review

Wolverine Trading sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 11,442 shares — an estimated $48K sold.

Wolverine Trading first reported a position in LJPC in Q4 2017 and held it in 5 quarters. The position peaked at $348K in Q4 2017. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

  • Wolverine Trading reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
  • Wolverine Trading sold 11,442 La Jolla Pharmaceutical Company shares in Q2 2020, an estimated $48K.
  • Wolverine Trading first reported a position in La Jolla Pharmaceutical Company in Q4 2017 and held it in 5 quarters.
  • Wolverine Trading's La Jolla Pharmaceutical Company position peaked at $348K in Q4 2017.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.